Centerpoint Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-89
Closed -$19K – 473
2026
Q2
$19K Sell
89
-1
-1% -$214 0.01% 276
2026
Q1
$20K Hold
90
– – 0.01% 243
2025
Q4
$23K Hold
90
– – 0.01% 222
2025
Q3
$22K Sell
90
-1
-1% -$239 0.01% 238
2025
Q2
$22K Hold
91
– – 0.01% 227
2025
Q1
$21K Hold
91
– – 0.01% 233
2024
Q4
$19K Hold
91
– – 0.01% 277
2024
Q3
$22K Hold
91
– – 0.01% 257
2024
Q2
$20K Hold
91
– – 0.01% 269
2024
Q1
$20K Hold
91
– – 0.01% 247
2023
Q4
$20K Hold
91
– – 0.01% 239
2023
Q3
$20K Sell
91
-1
-1% -$226 0.01% 230
2023
Q2
$21K Hold
92
– – 0.01% 243
2023
Q1
$18K Hold
92
– – 0.01% 275
2022
Q4
$17K Buy
+92
New +$16.2K 0.01% 228

Other funds holding STE

Centerpoint Advisors's STE Position: Q3 2026 in Review

Centerpoint Advisors sold out of Steris (STE) in Q3 2026, closing a stake of 89 shares — an estimated $19K sold.

Centerpoint Advisors first reported a position in STE in Q4 2022 and held it in 15 quarters. The position peaked at $23K in Q4 2025. 390 funds tracked by Wall St. Rank hold STE as of Q3 2026.

  • Centerpoint Advisors reported no remaining Steris position as of Q3 2026 after selling out during the quarter.
  • Centerpoint Advisors sold 89 Steris shares in Q3 2026, an estimated $19K.
  • Centerpoint Advisors first reported a position in Steris in Q4 2022 and held it in 15 quarters.
  • Centerpoint Advisors's Steris position peaked at $23K in Q4 2025.
  • 390 funds tracked by Wall St. Rank held Steris as of Q3 2026.

Based on Centerpoint Advisors's 13F filing for Q3 2026, filed 5 Nov 2026.